Lonza Group AG Lonza Group AG

Lonza Group AG

LONN

Classificação em ações #447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Preço da ação
$766.95
Valor de mercado
$53.57B
Variação (1 dia)
1.35%
Variação (1 ano)
9.01%
País
CH
Negociar Lonza Group AG (LONN)

Categoria

Healthcare
Histórico de desdobramentos de ações de Lonza Group AG (LONN)
As ações Lonza Group AG (símbolo: LONN) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Oct 22, 2026.
Uma ação LONN comprada antes de Oct 22, 2026 equivaleria hoje a 0 ações LONN.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
1 x2
US
0 -
US
1 x3
AU
0 -
NL
1 x100
BE